BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20443678)

  • 1. Clonal evolution in patients with chronic lymphocytic leukemia.
    Loscertales J; Arranz E; Sanz MA; Blas C; Gil-Fernández JJ; Burgaleta C; Alegre A
    Leuk Lymphoma; 2010 Jun; 51(6):1142-3. PubMed ID: 20443678
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal analysis of IgM+ CD5+ CLL B cells.
    Schettino EW; Newcomb EW; Potmesil M; Inghirami G; Casali P
    Ann N Y Acad Sci; 1995 Sep; 764():485-91. PubMed ID: 7486572
    [No Abstract]   [Full Text] [Related]  

  • 3. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
    Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
    Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
    Zenz T; Döhner H; Stilgenbauer S
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of microsatellite instability in human chronic lymphocytic leukaemia B cells.
    Praz F; Le Page F; Vallat L; Davi F; Nguyen-Khac F; Maloum K; Delic J; Merle-Béral H
    Leukemia; 2008 Jan; 22(1):186-9. PubMed ID: 17673901
    [No Abstract]   [Full Text] [Related]  

  • 6. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
    Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.
    Rodríguez CM; Stanganelli C; Bussi C; Arroyo D; Sastre D; Heller V; Iribarren P; Slavutsky I
    Leuk Lymphoma; 2018 May; 59(5):1239-1243. PubMed ID: 28868956
    [No Abstract]   [Full Text] [Related]  

  • 10. Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
    Sheikholeslami MR; Ma W; Uyeji J; Tornyos K; Cone L; Mamus S; Albitar M
    Br J Haematol; 2007 Nov; 139(3):507-9. PubMed ID: 17868045
    [No Abstract]   [Full Text] [Related]  

  • 11. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Cosson A; Chapiro E; Belhouachi N; Cung HA; Keren B; Damm F; Algrin C; Lefebvre C; Fert-Ferrer S; Luquet I; Gachard N; Mugneret F; Terre C; Collonge-Rame MA; Michaux L; Rafdord-Weiss I; Talmant P; Veronese L; Nadal N; Struski S; Barin C; Helias C; Lafage M; Lippert E; Auger N; Eclache V; Roos-Weil D; Leblond V; Settegrana C; Maloum K; Davi F; Merle-Beral H; Lesty C; Nguyen-Khac F;
    Genes Chromosomes Cancer; 2014 Aug; 53(8):657-66. PubMed ID: 24729385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
    Rodríguez AE; Hernández JÁ; Benito R; Gutiérrez NC; García JL; Hernández-Sánchez M; Risueño A; Sarasquete ME; Fermiñán E; Fisac R; de Coca AG; Martín-Núñez G; de Las Heras N; Recio I; Gutiérrez O; De Las Rivas J; González M; Hernández-Rivas JM
    PLoS One; 2012; 7(11):e48485. PubMed ID: 23152777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in IgHV Mutational Status of CLL Suggests Origin From Multiple Clones.
    Osman A; Gocke CD; Gladstone DE
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):97-99. PubMed ID: 28041846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
    Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
    Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia.
    Maura F; Visco C; Falisi E; Reda G; Fabris S; Agnelli L; Tuana G; Lionetti M; Guercini N; Novella E; Nichele I; Montaldi A; Autore F; Gregorini A; Barcellini W; Callea V; Mauro FR; Laurenti L; Foà R; Neri A; Rodeghiero F; Cortelezzi A
    Am J Hematol; 2013 Jan; 88(1):32-6. PubMed ID: 23115077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia with a FGFR3 translocation: case report and literature review of an uncommon cytogenetic event.
    Geller MD; Pei Y; Spurgeon SE; Durum C; Leeborg NJ
    Cancer Genet; 2014; 207(7-8):340-3. PubMed ID: 25441688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the clinical course and outcome in chronic lymphocytic leukemia.
    Rai KR; Chiorazzi N
    N Engl J Med; 2003 May; 348(18):1797-9. PubMed ID: 12724486
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal heterogeneity in membrane expression of CD5 in a patient with chronic lymphocytic leukemia.
    Hashimoto S; Dono M; Vinciguerra V; Silver J; Chiorazzi N
    Ann N Y Acad Sci; 1995 Sep; 764():482-4. PubMed ID: 7486571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.